John M. Maris
 John M. Maris | |
|---|---|
| Rayuwa | |
| Karatu | |
| Makaranta |
Wheeling University (en)  |
| Sana'a | |
| Sana'a |
pediatrician (en) |
John Matthew Maris kwararre ne a fannin ilimin likitan yara na Amurka. Shi ne Farfesa Giulio D'Angio Endowed Farfesa na Pediatrics a Asibitin Yara na Philadelphia (CHOP) da kuma cikakken Farfesa a makarantar medicine na parelman a jami'ar pennnsylvania.
Rayuwar farko da ilimi[gyara sashe | gyara masomin]
Maris ya kammala digirinsa na farrko na kimiyya daga Jami'ar Wheeling a 1983 da digirinsa na likitanci daga Makarantar Magunguna ta Perelman a Jami'ar Pennsylvania a 1989. [1]
Sana'a[gyara sashe | gyara masomin]
Bayan kammala karatunsa na yau da kullun, an nada Maris a matsayin mataimakin farfesa a fannin ilimin yara a Makarantar Magunguna ta Perelman a Jami'ar Pennsylvania a 1996. [2] Yayin aiki a cikin wannan rawar, Maris da ƙungiyar bincikensa sun mayar da hankali kan ciwon daji na yara neuroblastoma da fahimtar cututtukan ƙwayoyin cuta zuwa ingantattun ƙimar rayuwa. Sun yi amfani da dabarun haɗin kai, haɗa nau'ikan kwayoyin halitta da dabarun aiki don ba da fifiko ga maƙasudin ƙwayoyin cuta don cimma cikakkiyar tsarin kula da neuroblastoma. [3] Daga karshe an kara masa girma zuwa matsayin mataimakin farfesa kuma aka zabe shi ga kungiyar bincike kan yara . [4] Bayan haka, an kuma zaɓe shi ga Ƙungiyar Binciken Kiwon Lafiya ta Amirka a 2007. [3]
A cikin 2008, Maris ya jagoranci ƙungiyar da ta gano bambance-bambancen DNA na kowa akan chromosome 6, karo na farko da masu bincike suka gano asalin halittarsa. [5] Ya kuma yi aiki tare da likitan-masanin kimiyya Yael Moss don gwada maganin crizotinib a matsayin yiwuwar maganin neuroblastoma. [6] A shekara ta 2010, Maris an nada shi shugabar Oncology a Asibitin Yara na Philadelphia da kuma darektan Cibiyar Nazarin Ciwon Kankara ta Asibiti. [5] A cikin 2013, Maris da likita Crystal Mackall an nada su a matsayin masu haɗin gwiwa na Stand Up to Cancer -St. Baldrick's Foundation Immunogenomics Dream Team. Ƙungiyar binciken za ta yi amfani da kwayoyin halitta don gano maƙasudin maganin CAR T-cell. [7] A cikin Janairu 2013, Maris tare da haɗin gwiwar Haɗuwar Farfaɗo Targeting da Chk1 da Wee1 Kinases yana Nuna Ƙarfin Lafiya a cikin Neuroblastoma wanda shine haɗin gwiwar jami'an bincike ya rage girman ci gaban neuroblastomas a cikin mice. [8] Daga baya waccan shekarar, ya gwada maganin binciken LEE011 akan rage jinkirin ci gaban neuroblastomas a cikin mice. [9] Kungiyar Mafarki daga baya ta gano takamaiman takamaiman hari a cikin babban haɗari neuroblastoma kuma sun ƙirƙira tsarin salon salula wanda aka yiwa waɗannan makasudi tare da yin kisa mai ƙarfi akan ƙwayoyin ƙari. [10]
A yayin bala'in COVID-19, Ƙungiyar Mafarki ta Maris ta sami lambar yabo ta 2021 American Association for Cancer Research Team Science Award. [11]
Manazarta[gyara sashe | gyara masomin]
- ↑ "John Matthew Maris, M.D." upenn.edu. Retrieved May 30, 2021.
- ↑ "Faculty Appointment and Promotions, September 1996 through March 1997". upenn.edu. 1996. Retrieved May 30, 2021.
- ↑ 3.0 3.1 "John M. Maris, MD". the-asci.org. American Society for Clinical Investigation. Retrieved May 30, 2021.
- ↑ "13 Elected to Pediatric Societies". upenn.edu. January 11, 2005. Retrieved May 30, 2021.
- ↑ 5.0 5.1 "Pediatric Oncologist Reviews Current Progress Against Neuroblastoma". newswise.com. June 14, 2010. Retrieved May 30, 2021
- ↑ "Dr. John Maris: Teaming Up to End Childhood Cancer". aacr.org. Retrieved May 30, 2021
- ↑ "Neuroblastoma Expert to Lead Pediatric Dream Team". stbaldricks.org. St. Baldrick's Foundation. April 7, 2013. Retrieved May 30, 2021.
- ↑ "Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma". Therapeutics, Targets, and Chemical Biology. 73 (2). January 2013. Retrieved May 30, 2021
- ↑ Empty citation (help)
- ↑ "Science Center's Multi-Institutional Proof-of-Concept Program Awards $700,000 to Accelerate Technology Commercialization at Four Leading Institutions". prweb.com. February 6, 2019. Retrieved May 30, 2021
- ↑ "AACR to Recognize the St. Baldrick's Foundation-Stand Up To Cancer Pediatric Cancer Dream Team with 2021 Team Science Award". aacr.org. American Association for Cancer Research. April 8, 2021. Retrieved May 30, 2021.